비마토프로스트
BIMATOPROST
정의
Bimatoprost is the organic compound that conforms to the formula
별칭·식별 정보
BIMATOPROSTINCI비마토프로스트식약처 표준명BIMATOPROST동의어
- cas
- 155206-00-1
- dtxsid
- DTXSID30895042
- dtxcid
- DTXCID401324598
- IUPAC
- (5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
- 분자식
- C25H37NO4
- 분자량
- 415.574 g/mol
화장품에서 하는 역할
EYELASH CONDITIONING
안전·규제 요약
MFDS(식약처) 국가별 사용 제한/금지 기록
식약처 규제 요약: 금지 국가 아세안,캐나다,한국 / 제한 국가 없음
식약처 국가별 규제 정보: 아세안 · 금지
식약처 국가별 규제 정보: 캐나다 · 금지
식약처 국가별 규제 정보: 한국 · 금지
연결된 공식 원본 데이터
- MFDS cosmetics regulatory ingredient information · regulation_summary · 비마토프로스트
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 비마토프로스트
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 비마토프로스트
- MFDS cosmetics regulatory ingredient information · restricted_ingredient · 비마토프로스트
관련 문헌
- Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure · 2019
- Intracameral Sustained-Release Bimatoprost Implant Delivers Bimatoprost to Target Tissues with Reduced Drug Exposure to Off-Target Tissues · 2019
- Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes · 2013
- Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions · 2013
- Comparison of Human Ocular Distribution of Bimatoprost and Latanoprost · 2012